The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study
NCT ID: NCT04554134
Last Updated: 2020-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
550 participants
OBSERVATIONAL
2005-01-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Analysis of Functional CT Imaging of Coronary Atherosclerosis
NCT04986410
Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study
NCT04665817
The Correlation of Heart Hemodynamic Status Between 320 Multidetector Computed Tomography, Echocardiography and Cardiac Catheterization in Patients With Coronary Artery Disease
NCT01083134
CCTA Improves Clinical Management of Stable Chest Pain
NCT04691037
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
NCT06255769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Gender: All
3. coronary artery disease patients (CAD)
4. underwent CCTA, SPECT and coronary angiography (CAG) together within 3 months
5. Time: 2005-2015
Exclusion Criteria
2. Prior coronary revascularization;
3. permanent pacemaker or internal defibrillator
4. prosthetic heart valve
5. coronary image lose
6. coronary artery severe calcification
7. motion artifacts and poor CCTA image quality
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huai'an First People's Hospital
OTHER
Changzhou No.2 People's Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xu Zhihui
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yi Chai, MD
Role: STUDY_CHAIR
The First Affiliated Hospital Hospital of Nanjing Medical University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BK20141020
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2019-SR-242
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.